Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,084 across all filing types
Latest filing 2025-08-14 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
关于公司与业绩承诺方签订《补偿协议》的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by a listed company regarding the signing of a compensation agreement related to performance commitments tied to a previous acquisition. It details the background of the acquisition, the performance shortfall, impairment testing, and the agreed compensation scheme involving cash, dividends, and equity transfer. The document includes board meeting approvals and explanations of the impact on the company. It is a formal disclosure of a corporate event affecting ownership and financial arrangements but does not contain full financial statements or comprehensive financial performance data. It is not an annual or interim report, audit report, or earnings release. It is not a call transcript or investor presentation. The document is a regulatory announcement about a corporate transaction and related agreements, fitting best under Regulatory Filings (RNS). The document length is 4421 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2025-08-14 Chinese
2025年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2025 年半年度报告摘要" which translates to "2025 Semi-Annual Report Summary." It contains detailed financial data such as revenue, net profit, cash flow, earnings per share, and asset information for the half-year period. It also includes shareholder information, changes in control, and other corporate updates relevant to the half-year period. The document length is 3728 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or a link to a report. The presence of detailed financial metrics and company operational data for a half-year period clearly identifies this as an Interim / Quarterly Report. Therefore, the appropriate classification is IR (Interim / Quarterly Report). H1 2025
2025-08-14 Chinese
关于公司向银行申请综合授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's application for a comprehensive credit facility from a bank. It details the credit amount, terms, and board authorization for handling the credit facility. There is no financial report, earnings data, or regulatory certification. The document is a financing update about the company's capital structure and borrowing plans. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short but contains substantive information about financing, not just a notice or report publication.
2025-08-14 Chinese
股票交易异常波动公告暨风险提示公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement and risk warning from a listed company. It discusses recent share transfer agreements, stock price volatility, and risk factors related to a potential change in control. It references previous announcements and reports but does not contain financial statements or detailed financial data itself. The document is relatively short (2234 characters) and serves as a regulatory disclosure about stock price movements and related risks rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-07-27 Chinese
关于控制权拟发生变更的进展暨签署补充协议的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding a proposed change in control of the company, detailing a share transfer agreement and a supplementary agreement between the controlling shareholder and a new party. It includes information about the progress of the transaction, risk warnings, and references to regulatory approvals needed. There are no financial statements, earnings data, or detailed financial analysis present. The document is a formal announcement of a significant shareholding change and control transfer, not a full report or financial filing. Therefore, it fits best under the category of Major Shareholding Notification (MRQ). The document length is short (1540 characters), and it is not a report publication announcement or certification. Hence, the classification is MRQ with high confidence.
2025-07-25 Chinese
关于董事减持股份计划期限届满暨实施结果的公告
Director's Dealing Classification · 95% confidence The document is an announcement regarding the completion and results of a shareholding reduction plan by a company director (Mr. Xu Ke). It details the number of shares reduced, the method, dates, and compliance with relevant securities laws and regulations. The content focuses on insider share transactions by a director, including pre- and post-reduction holdings. There is no financial report, earnings data, or management discussion. The document fits the definition of 'Director's Dealing' which reports personal share transactions by company directors and executives (insider trades). The document length is short and it is not a report publication announcement or regulatory filing. Therefore, the correct classification is DIRS with high confidence.
2025-06-30 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.